about
Mathematical modelling of the evolution of protein distribution within single PLGA microspheres: prediction of local concentration profiles and release kinetics.Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics.Surface modified natural zeolite as a carrier for sustained diclofenac release: A preliminary feasibility study.Biocompatible nanoparticles sensing the matrix metallo-proteinase 2 for the on-demand release of anticancer drugs in 3D tumor spheroids.Nanocarriers to Enhance the Accumulation of Vitamin K1 into the Skin.Development of nanoemulsions for topical delivery of vitamin K1.Dynamics of nanoparticle diffusion and uptake in three-dimensional cell cultures.Controlled drug delivery in tissue engineering.Surface modified zeolite-based granulates for the sustained release of diclofenac sodium.Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles.Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.Tumor-activated prodrug (TAP)-conjugated nanoparticles with cleavable domains for safe doxorubicin delivery.Sub-100 nm biodegradable nanoparticles: in vitro release features and toxicity testing in 2D and 3D cell cultures.Design of electrospayed non-spherical poly (L-lactide-co-glicolide) microdevices for sustained drug delivery.Investigation of the mechanisms governing doxorubicin and irinotecan release from drug-eluting beads: mathematical modeling and experimental verification.Engineering poly(ethylene oxide) buccal films with cyclodextrin: a novel role for an old excipient?Nano-precipitated curcumin loaded particles: effect of carrier size and drug complexation with (2-hydroxypropyl)-β-cyclodextrin on their biological performances.Bioactivated collagen-based scaffolds embedding protein-releasing biodegradable microspheres: tuning of protein release kinetics.New Insights into the Mechanisms of the Interactions Between Doxorubicin and the Ion-Exchange Hydrogel DC Bead™ for Use in Transarterial Chemoembolization (TACE)Surfactant-modified phillipsite and chabazite as novel excipients for pharmaceutical applications?Combination therapy for the treatment of pancreatic cancer through hyaluronic acid-decorated nanoparticles loaded with quercetin and gemcitabine: A preliminary in vitro studyInjectable Thermally Responsive Mucoadhesive Gel for Sustained Protein DeliveryEngineering of thermoresponsive gels as a fake metastatic nicheAmphiphilic hyaluronic acid derivatives toward the design of micelles for the sustained delivery of hydrophobic drugs
P50
Q30835996-A030AF83-D133-4AB8-812B-68AFA1D3D3F3Q33247370-8EE9583B-CAAB-468F-9CC9-159DF06FBEC5Q35616721-525C9014-882A-40A8-8ECF-A7C28C0EA2A5Q35764709-ECFF5B30-5D3E-477E-903E-273A4C74A9F8Q35856187-AECB6139-5D68-46B2-BA28-BF83DB13A387Q36069533-2422F5D4-B44A-449D-BFE4-E7BE7AAA7450Q36154827-A1739BFB-E075-4196-9CF2-4596D4162CFEQ37010625-2CC12EB5-302A-41EA-A368-9FA73158CB71Q38724454-661097D8-2C6F-4E50-9A64-C4AE1335EE72Q38794144-47935898-A095-497A-9811-90B748CF80C4Q38897035-CD5F43AC-D30C-4838-BC3A-E2E170CEDF3BQ38956549-3EC7E3E5-3366-40FB-B17D-7EA5EC09BEEAQ39215479-07567F6C-66D5-4329-AA4E-333FC0C4EAB9Q43926930-23FC8F24-EE48-48FA-9B6C-A2186CFC5181Q44459189-EE0324F4-9BCF-40EF-88FF-E5D9A4C4D811Q45852704-40F3FAD9-3BF3-4F8F-9974-62CFB7A252B5Q47239760-831312C9-DE1F-4664-90BF-010DE4BB7377Q47780010-76A4758D-BD76-4A41-B266-E0FDCD1D59F8Q57371751-C571B7AF-D625-4A37-AA5F-42B16C512C3BQ57854928-CC4EADB2-91F3-4989-BE11-F1A3FCA51AE1Q58598004-8DDED6AF-EBF8-4EFB-83DE-70E103B514FCQ60218755-8697C0CA-898A-475D-A691-EE591378AA70Q61986977-EA5A34C8-8EC4-4134-AB8D-A4CA7BD2C188Q61986983-30D447DD-6187-46A4-B453-99E504C95A72
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marco Biondi
@ast
Marco Biondi
@en
Marco Biondi
@es
Marco Biondi
@nl
Marco Biondi
@sl
type
label
Marco Biondi
@ast
Marco Biondi
@en
Marco Biondi
@es
Marco Biondi
@nl
Marco Biondi
@sl
prefLabel
Marco Biondi
@ast
Marco Biondi
@en
Marco Biondi
@es
Marco Biondi
@nl
Marco Biondi
@sl
P106
P1153
35336117100
P21
P31
P496
0000-0001-7299-9958